Psoriatic Arthritis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy and safety of guselkumab in biologic-na ïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial
This study will evaluate the ability of guselkumab to reduce both axial symptoms and inflammation in patients with active PsA.Trial registrationThis trial was registered at ClinicalTrials.gov,NCT04929210, on 18 June 2021.Protocol version: Version 1.0 dated 14 April 2021. (Source: Trials)
Source: Trials - September 5, 2022 Category: Research Source Type: clinical trials

Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
Condition: Psoriatic Arthritis Interventions: Drug: ATI-450; Drug: Placebo Oral Tablet Sponsor: Aclaris Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2022 Category: Research Source Type: clinical trials

Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis
Conditions: Psoriasis Vulgaris; Active Psoriatic Arthritis Intervention: Drug: Bimekizumab Sponsors: Innovaderm Research Inc.; Ciusss de L'Est de l'Île de Montréal Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2022 Category: Research Source Type: clinical trials